Literature DB >> 23873589

The impact of anti-inflammatory cytokines provoked by CD163 positive macrophages on ventricular functional recovery after myocardial infarction.

Takao Sato1, Tomoki Kameyama, Takahisa Noto, Teruo Nakadate, Hiroshi Ueno, Kunihiro Yamada, Hiroshi Inoue.   

Abstract

Present study aimed to investigate the impact of anti-inflammatory cytokines provoked by the hemoglobin scavenger receptor, CD163, on left ventricular (LV) functional recovery after successful reperfusion in patients with acute myocardial infarction (AMI). Intraplaque hemorrhage accelerates plaque destabilization. Extracellular hemoglobin is cleared by CD163, a macrophage scavenger receptor. This process provokes secretion of anti-inflammatory atheroprotective cytokine, interleukin (IL)-10. In 40 patients with the first AMI, coronary atherothrombotic debris was retrieved during percutaneous coronary intervention (PCI), stained with antibodies to CD163 and IL-10. LV function was determined by echocardiography before PCI and 6 months after PCI. %CD163 was defined as ratio of CD163 (+)-cells to whole cells. %IL-10 was expressed as the ratio of positively stained areas per total tissue. Patients were divided into two groups depending on the amount of CD163 (+)-cells: CD163 > 10 % (CD163high, n = 20) and CD163 ≤ 10 % (CD163low, n = 20). CD163high group had significantly higher %IL-10. Final thrombolysis in myocardial infarction (TIMI) flow grade was significantly lower in CD163high group. In subgroups with the final TIMI-3 flow (CD163high-Reflow, n = 15 and CD163low-Reflow, n = 20), the time to reperfusion, infarct size, LV dimensions and fractional shortening (%FS) before PCI were similar. Significant correlation was observed between %IL10 and changes in LV dimensions (diastole, r = -0.49, P = 0.01; systole, r = -0.65, P < 0.01) or %FS (r = 0.51, P < 0.01) at 6 months after PCI. Plaque with CD163(+)-macrophages could impair distal flow after primary PCI. However, CD163(+)-macrophages enhance the anti-inflammatory cytokine expression that aids in ventricular functional recovery if distal flow can be achieved by successful reperfusion.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 23873589     DOI: 10.1007/s11239-013-0971-3

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  30 in total

1.  Reciprocal induction of IL-10 and IL-12 from macrophages by low-density lipoprotein and its oxidized forms.

Authors:  A S Varadhachary; M Monestier; P Salgame
Journal:  Cell Immunol       Date:  2001-10-10       Impact factor: 4.868

2.  Phenotypic dynamics of macrophage subpopulations during human experimental gingivitis.

Authors:  H H Topoll; G Zwadlo; D E Lange; C Sorg
Journal:  J Periodontal Res       Date:  1989-03       Impact factor: 4.419

Review 3.  What have we learned about plaque rupture in acute coronary syndromes?

Authors:  So-Yeon Choi; Gary S Mintz
Journal:  Curr Cardiol Rep       Date:  2010-07       Impact factor: 2.931

4.  Serum level of the antiinflammatory cytokine interleukin-10 is an important prognostic determinant in patients with acute coronary syndromes.

Authors:  Christopher Heeschen; Stefanie Dimmeler; Christian W Hamm; Stephan Fichtlscherer; Eric Boersma; Maarten L Simoons; Andreas M Zeiher
Journal:  Circulation       Date:  2003-03-31       Impact factor: 29.690

5.  Initial cytokine exposure determines function of macrophages and renders them unresponsive to other cytokines.

Authors:  L P Erwig; D C Kluth; G M Walsh; A J Rees
Journal:  J Immunol       Date:  1998-08-15       Impact factor: 5.422

6.  Distal protection with a filter device during coronary stenting in patients with stable and unstable angina.

Authors:  Annalisa Angelini; Paolo Rubartelli; Flavio Mistrorigo; Mila Della Barbera; Francesco Abbadessa; Massimo Vischi; Gaetano Thiene; Sergio Chierchia
Journal:  Circulation       Date:  2004-07-26       Impact factor: 29.690

7.  Human atrial natriuretic peptide and nicorandil as adjuncts to reperfusion treatment for acute myocardial infarction (J-WIND): two randomised trials.

Authors:  Masafumi Kitakaze; Masanori Asakura; Jiyoong Kim; Yasunori Shintani; Hiroshi Asanuma; Toshimitsu Hamasaki; Osamu Seguchi; Masafumi Myoishi; Tetsuo Minamino; Takahiro Ohara; Yoshiyuki Nagai; Shinsuke Nanto; Kouki Watanabe; Shigeru Fukuzawa; Atsushi Hirayama; Natsuki Nakamura; Kazuo Kimura; Kenshi Fujii; Masaharu Ishihara; Yoshihiko Saito; Hitonobu Tomoike; Soichiro Kitamura
Journal:  Lancet       Date:  2007-10-27       Impact factor: 79.321

Review 8.  Cardiac remodeling--concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling.

Authors:  J N Cohn; R Ferrari; N Sharpe
Journal:  J Am Coll Cardiol       Date:  2000-03-01       Impact factor: 24.094

9.  Enhanced expression of haemoglobin scavenger receptor in accumulated macrophages of culprit lesions in acute coronary syndromes.

Authors:  Kei Yunoki; Takahiko Naruko; Ryushi Komatsu; Shoichi Ehara; Nobuyuki Shirai; Kenichi Sugioka; Masashi Nakagawa; Chizuko Kitabayashi; Yoshihiro Ikura; Akira Itoh; Kengo Kusano; Tohru Ohe; Kazuo Haze; Anton E Becker; Makiko Ueda
Journal:  Eur Heart J       Date:  2009-06-25       Impact factor: 29.983

10.  Prognostic significance of serial changes in left ventricular ejection fraction in patients with congestive heart failure. The V-HeFT VA Cooperative Studies Group.

Authors:  G Cintron; G Johnson; G Francis; F Cobb; J N Cohn
Journal:  Circulation       Date:  1993-06       Impact factor: 29.690

View more
  1 in total

1.  Identification of potential biomarkers of inflammation-related genes for ischemic cardiomyopathy.

Authors:  Jianru Wang; Shiyang Xie; Yanling Cheng; Xiaohui Li; Jian Chen; Mingjun Zhu
Journal:  Front Cardiovasc Med       Date:  2022-08-23
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.